Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-001928
Filing Date
2025-01-23
Accepted
2025-01-23 16:16:26
Documents
1
Period of Report
2025-01-21

Document Format Files

Seq Description Document Type Size
1 form4-01232025_090122.html 4  
1 form4-01232025_090122.xml 4 3514
  Complete submission text file 0001415889-25-001928.txt   5133
Mailing Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087
Business Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS, INC. (Issuer) CIK: 0001267813 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O TREVENA, INC. 955 CHESTERBROOK BOULEVARD, STE. 110 CHESTERBROOK PA 19087
Business Address
Johnson Marvin (Reporting) CIK: 0001852752 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36576 | Film No.: 25550340